ASTELLAS PHARMA INC./ JP3942400007 /
07.11.2024 19:39:08 | Изменение -0.040 | Объем сделки | Бид21:55:02 | Предложение21:55:02 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
10.400EUR | -0.38% | 3,451 Оборот: 36,081.035 |
10.145Величина цены спроса: 481 | 10.460Величина цены предложения: 472 | 18.94 млрдEUR | - | - |
GlobeNewswire
14.08
Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD...
GlobeNewswire
08.08
Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
GlobeNewswire
16.04
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Dir...
GlobeNewswire
19.03
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degene...
GlobeNewswire
26.02
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
07.02
LAPIX Therapeutics Strengthens Board of Directors with Appointments of Pharmaceutical Industry Veter...
GlobeNewswire
11.12.2023
Basilea announces that FDA approves expanded use of antifungal Cresemba® (isavuconazole) in the Unit...
GlobeNewswire
19.10.2023
Basilea announces acquisition of novel clinical-stage antifungal for treatment of Aspergillus mold i...
GlobeNewswire
14.09.2023
Mineralys Therapeutics Expands its Board of Directors with Appointments of Glenn Sblendorio and Daph...
GlobeNewswire
11.09.2023
Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница